E-mail this page: News Release

Warner Chilcott Completes Acquisition of U.S. Rights to Enablex(R) Overactive Bladder Treatment for $400 Million in Cash

To (e-mail address):   Separate multiple addresses with commas. Maximum 200 characters.
Your name:
Your e-mail address:   Copy yourself These e-mail addresses will be used to e-mail the page on your behalf and will not be used by Warner Chilcott for any marketing purposes.
Add a comment:
Send:    Full page    Link to page
Type in number:
This helps Warner Chilcott prevent automated submissions.